Stock Taper
SCREENER COMPARE ANY 2 STOCKS
IMRN
IMMURON LIMITED
NASDAQ
$1.15
▼ DOWN 1.29% (-0.01)

KEY STATISTICS

Market Cap$7.41 M
52w High$2.39
52w Low$0.68
Dividend Yield—
Frequency—
P/E-5.59
Volume7.00K
Shares Out.6.45M

COMPANY

LEADERSHIP

Steven George Lydeamore
CHIEF EXECUTIVE
Steven George Lydeamore

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 9, 2017
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
7

UPCOMING EARNINGS

DateFeb 19, 2027
DayFriday
Rev. Est.$3.36M
FEB
19
FRI

PRICE

$1.15 ▼ DOWN 1.29% (−$0.01)
$1.16$1.16$1.179:40 AM10:43 AM11:46 AM12:50 PM1:53 PM2:56 PM3:59 PM1.15

About Immuron Limited

https://www.immuron.com.au ↗

Immuron Limited is an Australian biopharmaceutical company developing and commercializing polyclonal antibodies, including products like Travelan and Protectyn, and advancing clinical-stage therapies for infections and viral diseases.

INDUSTRY

Biotechnology

A PRODUCT IMMURON LIMITED IS KNOWN FOR

Travelan®
Travelan®

Travelan® is an over-the-counter oral immunotherapy by Immuron that reduces traveler's diarrhea risk, with growing sales in Australia and the U.S., and is undergoing clinical trials to enhance efficacy and market expansion.

COMPETITORS

COMPETITOR
ABBV COMPARE
BHC COMPARE
IRWD COMPARE
JAGX COMPARE
RDHL COMPARE

Revenue by Products

IconPRODUCTFY2019FY2020FY2021
Travelan$2.33M — —
ProtectynMember— — $50.18K
Protectyn$59.05K $49.93K ▼—

INSTITUTIONAL OWNERSHIP

SHARES OWNED
2.65%
HOLDERS
11
TOP 11 OF 11 · RANKED BY POSITION SIZE
Morgan Stanley
57.4K sh · $43.75K
Citadel Advisors LLC
45.8K sh · $34.91K
Jane Street Group, LLC
22.5K sh · $17.12K
Xtx Topco Ltd
18.0K sh · $34.32K
Virtu Financial LLC
11.4K sh · $9K
Rhumbline Advisers
5.9K sh · $11.34K
Bnp Paribas Arbitrage, Snc
4.7K sh · $3.58K
Ubs Group AG
4.1K sh · $3.16K
Ladenburg Thalmann Financial Services Inc.
1.0K sh · $4K
Sbi Securities Co., Ltd.
10 sh · $8
Concourse Financial Group Securities, Inc.
0 sh · $0

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF COMMERCIAL OFFICER
Palumbo Flavio
— · —
2026-03-18
★
OFFICER: CHIEF COMMERCIAL OFFICER
Palumbo Flavio
— · 640.8K shares
2024-10-24
★
DIRECTOR
Pollock Daniel Jude
— · —
2026-03-18
★
DIRECTOR
Pollock Daniel Jude
— · 333.3K shares
2025-12-08

SECTORS PEERS

PEERPRICE
DWTX$2.65COMPARE
CLRB$2.53COMPARE
COCP$1.10COMPARE
TRAW$0.59COMPARE
BOLT$3.81COMPARE
IMNN$1.60COMPARE
BRTX$0.20COMPARE
EVGN$0.55COMPARE